Oltmans Curtis Gale
SEC insider (Form 3/4/5 filer). CIK 0001714982. Chief Legal Officer at Fulcrum Therapeutics, Inc. (FULC) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 2, 2026. Located in CAMBRIDGE, MA.
Companies Oltmans Curtis Gale has filed insider reports for
- Fulcrum Therapeutics, Inc. (FULC): Officer, Chief Legal Officer
- AVENUE THERAPEUTICS, INC. (ATXI): Director
Oltmans Curtis Gale
CIK: 0001714982
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 2, 2026FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
170K shares- - Dec 15, 2025FULC
Fulcrum Therapeutics, Inc.
SaleDirect3.5K shares at avg. $12.92$45K - Jan 24, 2025FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
225K shares- - Sep 23, 2024ATXI
AVENUE THERAPEUTICS, INC.
AwardDirectEmployee stock option (right to buy)
30K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 2, 2026 |  FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 170,000 | - | - | Direct |
| Dec 15, 2025 | FULC Fulcrum Therapeutics, Inc. | Sale | 3,452 | $12.92 | $44,600 | Direct |
| Jan 24, 2025 | FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 225,000 | - | - | Direct |
| Sep 23, 2024 |  ATXI AVENUE THERAPEUTICS, INC. | Award Employee stock option (right to buy) | 30,000 | - | - | Direct |
1-4 of 4 transactions